dihexa hgf c-met cancer risk

dihexa hgf c-met cancer risk HGF/c-MET pathway in cancer: from molecular characterization to clinical evidence dihexa c-met cancer risk Developing

Name: dihexa hgf c-met cancer risk HGF/c-MET pathway in cancer: from molecular characterization to clinical evidence dihexa c-met cancer risk Developing
Brand: usmivani.cz
SKU: 73823927897
Price: 23.09 USD
Availability: InStock
Rating: 4.739800000000001 (26 reviews)

dihexa c met cancer risk Developing pathway inhibitors for therapy: progress and challenges: Trends in Molecular Medicine Activated HGF c Met Axis in Head Downstream signalling and specific inhibition of c MET HGF pathway in small cell lung cancer: implications for tumour invasion British Journal of Cancer c MET: A Key Target in Cancer Therapy HGF and MET: From Brain Development to Neurological Disorders PMC

SKU: 73823927897 · From usmivani.cz

4.7

USD23.09 USD56.09

Pay in 4 interest-free payments of $5.77 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 3 - Aug 8

Description

doi:10.1016/j.yhbeh.2015.06.020 Movsas TZ, Weiner RL, Greenberg MB, Holtzman DM, Galindo R

Third-party tested purity levels Batch-specific documentation Proper cold chain shipping Research compliance support Important: Always verify supplier credentials before purchasing peptides for research